C. Gazaille

Polymer-free hydrogel made of lipid nanocapsules, as a local drug delivery platform.

J. Benoit, R. Perrot, G. Bastiat, 2021, Materials science & engineering. C, Materials for biological applications.

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

T. Larcher, I. Anegon, B. Fraysse, 2021, Journal of translational medicine.

Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules

G. Bastiat, P. Saulnier, N. Lautram, 2021, Pharmaceutical Research.

Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?

G. Bastiat, P. Saulnier, J. Eyer, 2021, Frontiers in Medical Technology.

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.

V. Préat, G. Bastiat, Umer Farooq, 2023, Biomaterials advances.

The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.

J. Eyer, C. Gazaille, G. Leneweit, 2023, International journal of pharmaceutics.